<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02299934</url>
  </required_header>
  <id_info>
    <org_study_id>14-1213</org_study_id>
    <nct_id>NCT02299934</nct_id>
  </id_info>
  <brief_title>3T MR Angiography of the Hepatic Vasculature</brief_title>
  <official_title>3T MR Angiography of the Hepatic Vasculature: A Pilot Comparison Study of New Noncontrast Techniques to Post-contrast Technique and CT Angiography in Liver Donors.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Colorado, Denver</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Colorado, Denver</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study plans to learn more about the two Magnetic Resonance Angiography (MRA) techniques.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will use two Magnetic Resonance Angiography (MRA) techniques that will look at
      participants liver veins and arteries without giving a coloring matter (contrast) before
      taking the images. Investigators propose to evaluate the usefulness of these two new
      techniques, which do not involve exposing participants to radiation or contrast.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    lack of support
  </why_stopped>
  <start_date>July 2014</start_date>
  <completion_date type="Actual">December 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Liver Blood Supply Diameters</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Visibility of the Variations of the Liver Blood Supply</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Detection Rates of the Variations of the Liver Blood Supply</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Percentage of Examinations With the Presence of Significant Artifacts Interfering Interpretation.</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>How Badly the Artifacts Prevented Evaluation by the Reader.</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The Relative Signal Intensity of the Liver Blood Supply</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Documentation of Acquisition Time</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The Percentage of Examinations That Caused Adverse Events</measure>
    <time_frame>Day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Liver Blood Supply</condition>
  <arm_group>
    <arm_group_label>Subjects who fulfill the criteria for living liver donation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Magnetic Resonance Imaging (MRI)</intervention_name>
    <description>MRI sequences for visualisation of the blood supply of liver without contrast agent.</description>
    <arm_group_label>Subjects who fulfill the criteria for living liver donation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Compurtized Tomgraphy (CT)</intervention_name>
    <description>CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
    <arm_group_label>Subjects who fulfill the criteria for living liver donation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects that fulfill the criteria for living liver donation and are evaluated for the
             procedure with CT and MR.

        Exclusion Criteria:

          -  Unable to give informed consent

          -  Unable to comply with breathing or other imaging related instructions resulting in
             inability to obtain diagnostic quality MRI studies

          -  Not suitable to undergo MRI with a gadolinium-based contrast agent because of:

               -  Claustrophobia, unless patient agrees to sedation measures per institutional
                  standard practice during MR imaging

               -  Presence of metallic objects or implanted medical devices in body per
                  institutional safety standards

               -  Weight greater than that allowable by the MR table

               -  Renal failure, as determined by estimated glomerular filtration rate (eGFR) &lt; 30
                  mL/min/1.73 m2 by the Modification of Diet in Renal Disease (MDRD) model based on
                  a serum creatinine level obtained within 28 days prior to enrollment

               -  Known allergy-like reaction to contrast media (gadolinium) or moderate or severe
                  allergic reactions to one or more allergens as defined by the American College of
                  Radiology (ACR), and unwillingness to undergo pre-treatment as defined by the
                  institution`s policy and/or ACR guidance

               -  Pregnancy (if a female is of childbearing potential --defined as a premenopausal
                  female capable of becoming pregnant --a pregnancy test should be done)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Chang</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <reference>
    <citation>Puippe GD, Alkadhi H, Hunziker R, Nanz D, Pfammatter T, Baumueller S. Performance of unenhanced respiratory-gated 3D SSFP MRA to depict hepatic and visceral artery anatomy and variants. Eur J Radiol. 2012 Aug;81(8):e823-9. doi: 10.1016/j.ejrad.2012.02.016. Epub 2012 May 10.</citation>
    <PMID>22578837</PMID>
  </reference>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>November 14, 2014</study_first_submitted>
  <study_first_submitted_qc>November 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 24, 2014</study_first_posted>
  <results_first_submitted>February 21, 2019</results_first_submitted>
  <results_first_submitted_qc>April 15, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">May 7, 2019</results_first_posted>
  <last_update_submitted>April 15, 2019</last_update_submitted>
  <last_update_submitted_qc>April 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 7, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Participant data will only be shared to research personnel.</ipd_description>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 28, 2014</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/34/NCT02299934/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
          <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Termination of study</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>13 patients were consented and began the preliminary examination. 11 completed the preliminary examination after consenting.</population>
      <group_list>
        <group group_id="B1">
          <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
          <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="13"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="13"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Liver Blood Supply Diameters</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>Liver Blood Supply Diameters</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Visibility of the Variations of the Liver Blood Supply</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>The Visibility of the Variations of the Liver Blood Supply</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Detection Rates of the Variations of the Liver Blood Supply</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>Detection Rates of the Variations of the Liver Blood Supply</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Percentage of Examinations With the Presence of Significant Artifacts Interfering Interpretation.</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Examinations With the Presence of Significant Artifacts Interfering Interpretation.</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>How Badly the Artifacts Prevented Evaluation by the Reader.</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>How Badly the Artifacts Prevented Evaluation by the Reader.</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>The Relative Signal Intensity of the Liver Blood Supply</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>The Relative Signal Intensity of the Liver Blood Supply</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Documentation of Acquisition Time</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>Documentation of Acquisition Time</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Percentage of Examinations That Caused Adverse Events</title>
        <time_frame>Day 1</time_frame>
        <population>Study was terminated prior to collecting any outcome measure data.</population>
        <group_list>
          <group group_id="O1">
            <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
            <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
          </group>
        </group_list>
        <measure>
          <title>The Percentage of Examinations That Caused Adverse Events</title>
          <population>Study was terminated prior to collecting any outcome measure data.</population>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Duration of study activity (approximately 2 years)</time_frame>
      <desc>This study was terminated early due to lack of enrollment. No adverse events data was reported prior to early termination</desc>
      <group_list>
        <group group_id="E1">
          <title>Subjects Who Fulfill the Criteria for Living Liver Donation</title>
          <description>Subjects who fulfill the criteria for living liver donation and are evaluated for the procedure with Computerized Tomography (CT) and Magnetic Resonance Imaging (MRI).
Magnetic Resonance Imaging (MRI): MRI sequences for visualisation of the blood supply of liver without contrast agent.
Compurtized Tomgraphy (CT): CT including CT Angiography (CTA) for the evaluation of hepatic vasculature.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="13"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Study was terminated prior to collecting any outcome measure data or performing any image analysis.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Samuel Chang</name_or_title>
      <organization>University of Colorado, Denver</organization>
      <phone>720-848-1875</phone>
      <email>SAMUEL.CHANG@UCDENVER.EDU</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

